BOSTON ADVISORS LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 13 filers reported holding Astellas Pharma Inc in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BOSTON ADVISORS LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2019$161,000
-74.2%
11,295
-74.3%
0.01%
-75.8%
Q2 2019$625,000
-5.0%
43,9660.0%0.03%
-2.9%
Q1 2019$658,000
+37.9%
43,966
+15.7%
0.03%
+21.4%
Q4 2018$477,000
-23.3%
38,003
+6.7%
0.03%
+3.7%
Q3 2018$622,000
+15.2%
35,632
+0.0%
0.03%
+92.9%
Q2 2018$540,000
+0.7%
35,626
+1.6%
0.01%0.0%
Q1 2018$536,000
+29.5%
35,069
+7.3%
0.01%
+55.6%
Q4 2017$414,000
+2.7%
32,675
+2.8%
0.01%0.0%
Q3 2017$403,000
+3.6%
31,8000.0%0.01%0.0%
Q2 2017$389,000
-7.2%
31,8000.0%0.01%
-10.0%
Q1 2017$419,000
+39.2%
31,800
+46.2%
0.01%
+42.9%
Q4 2016$301,00021,7500.01%
Other shareholders
Astellas Pharma Inc shareholders Q1 2018
NameSharesValueWeighting ↓
THOMAS WHITE INTERNATIONAL LTD 659,892$10,254,0001.47%
TODD ASSET MANAGEMENT LLC 963,505$15,048,0000.46%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 694,200$10,843,0000.14%
SCOUT INVESTMENTS, INC. 179,686$2,792,0000.08%
Boston Common Asset Management, LLC 60,610$942,0000.05%
L & S Advisors Inc 10,000$156,0000.04%
QUADRANT CAPITAL GROUP LLC 3,443$49,0000.03%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 1,012,486$15,815,0000.02%
OLD NATIONAL BANCORP /IN/ 12,094$188,0000.01%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 181,668$2,838,0000.01%
View complete list of Astellas Pharma Inc shareholders